Pioneering diagnostics

Healthcare-associated infections

bioMérieux is very active in the fight against healthcare-associated infections (HAIs). We offer a comprehensive product range for healthcare professionals covering prevention, surveillance and diagnosis.
 

bioMérieux is a key player in the fight against healthcare-associated infections. We work closely with healthcare professionals in the three areas of healthcare-associated infection control:

  • Prevention: screening of patients at risk of healthcare-associated infections and environmental monitoring;
  • Surveillance: management of information (alerts, epidemiology studies, etc.);
  • Intervention: diagnosis of healthcare-associated infections and management of outbreaks.

Diagnostic tests are paramount in successfully fighting HAIs. They contribute to:

  • Decreasing or stabilizing the number of healthcare-associated infections;
  • Appropriate patient management and treatment;
  • Implementing preventive measures;
  • Improving healthcare quality and patient safety in the long term;
  • Shorter hospital stays resulting in reduced hospital costs.

 Focus - Clostridium difficile

With its VIDAS® C. difficile GDH and VIDAS® GDH tests, bioMérieux provides a comprehensive product offering for the diagnosis of C. difficile. Clostridium difficile is the chief infectious cause of healthcare and antibiotic-associated diarrhea, particularly among the elderly. Diagnosing C. difficile infections is a key step to improve patient outcomes. In addition, an accurate and rapid diagnosis makes it possible to stop contamination within hospitals and reduce the high costs associated with such infections.

 

 The Smart Bandage Project

Since 2015 bioMérieux has coordinated Smart Bandage, a collaborative R&D project financed by the European Regional Development Fund (ERDF), also involving the competitive bio-clusters Lyonbiopole and Techtera. The aim of this project is to develop a microbial biosensor embedded in a dressing for exuding wounds for the early detection of drug-resistant bacteria associated with HAIs.